Novartis aims to solve EpiPen shortage with generic launch of Symjepi to US pharmacies
July 10, 2019Manufacturing and Production, Research and Development, Sales and Marketing Mylan, Novartis, Sandoz, US, epipen, pharma
Novartis has announced the immediate availability of its generic epinephrine auto-injector in pharmacies throughout the US, as it moves to …
WHO leaves breakthrough cancer therapies off updated Essential Medicines List
July 10, 2019Research and Development Cancer, EML, WHO, essential medicines list, oncology, pharma, world health organization
The World Health Organization (WHO) has updated its list of essential medicines to include 28 more drugs. The WHO’s Essential …
ViiV Healthcare’s two drug HIV therapy beats Gilead’s three drug treatment in Phase 3 trial
July 10, 2019Research and Development AIDS, Dovato, GSK, Gilead, HIV, ViiV, pharma
Pfizer and GlaxoSmithKline’s HIV company, ViiV Healthcare, has said its two-drug combo Dovato (dolutegravir and lamuvidine) met its primary endpoint …
NHS to try out new subscription style payment model to pay for antibiotics
July 9, 2019Research and Development AMR, NHS, UK, health, payment models, pharma
The NHS has said it will test the world’s first subscription style payment model to pay for antibiotics. Britain’s National …
NICE recommends Alnylam’s Onpattro for inherited hATTR amyloidosis
July 9, 2019Manufacturing and Production, Sales and Marketing Alnylam, NHS, Onpattro, UK, hATTR amyloidosis, pharma
It’s good news for UK patients as it emerges that the National Institute of Health and Care Excellence has passed …
US Judge blocks Trump administration law requiring pharma to include prices in TV ads
July 9, 2019Manufacturing and Production Amgen, Eli Lilly, MSD, TV ads, Trump, USA, court, pharma
A judge has blocked the Trump administration from enacting a law that would require pharmaceutical companies to include the prices …
Roche unveils wave of strong Hemlibra data in haemophilia A with or without factor VIII inhibitors
July 9, 2019Manufacturing and Production, Research and Development Roche, haemophilia, pharma
Roche revealed a swathe of new data on Hemlibra (emicizumab) at the International Society on Thrombosis and Haemostasis (ISTH) 2019 …
Altaire Pharmaceuticals recalls OTC products
July 9, 2019Manufacturing and Production Altaire Pharmaceuticals, US, recall, walmart
Aquebogue, New York-based firm Altaire Pharmaceuticals has enacted a voluntary recall of a number of products sold in Walmart and …
Boys in UK to be given HPV vaccine
July 9, 2019Manufacturing and Production HPV, HPV vaccine, Vaccine, cervical cancer, oncology, pharma
Boys in the United Kingdom will from September be given the human papilloma virus (HPV) vaccine, the government has said. …
Insider Interview: A roadblock for counterfeit drugs?
July 8, 2019Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Merck KGaA, blockchain, fake drugs, feature, pharma
Dr Thomas Endress, Founder, and Dr Frederic Berkermann, co-?Founder, of a new technology being developed at the Merck Innovation Center …
Pierre Fabre’s triplet therapy makes strong showing in BRAF V600E-mutant metastatic colorectal cancer
July 8, 2019Research and Development, Sales and Marketing Cancer, Pierre Fabre, colorectal cancer, pharma
Pierre Fabre chose the European Society for Medical Oncology (ESMO) 21st World Congress on Gastrointestinal Cancer in Barcelona, Spain, to …
Government to set up express freight service for medicines in case of no-deal Brexit
July 8, 2019Sales and Marketing Transport, brexit, government, no-deal, pharma, planning
The Department of Health and Social Care (DHSC) plans to spend £3 million on emergency transport solutions for medicines in …
Pfizer and Sangamo’s haemophilia A gene therapy shows promise at Phase 1/2
July 8, 2019Research and Development, Sales and Marketing Pfizer, Sangamo, haemophilia, pharma
Pfizer and Sangamo Therapeutics have shared new Phase 1/2 data for their investigational SB-525 gene therapy in the treatment of …
New urine test can diagnose and offer prognosis for prostate cancer
July 8, 2019Sales and Marketing Cancer, oncology, pharma, prostate cancer, urine test
A new urine test can diagnose cases of aggressive prostate cancer more quickly than invasive biopsies. The test can also …
Trump says executive order will ensure US will pay lowest prices in the world for drugs
July 8, 2019Sales and Marketing Trump, US, executive order, pharma, politics, pricing
President Donald Trump has said that the White House is working on a ‘favoured nation clause’ to ensure the United …
GSK opens new manufacturing plants in Singapore
July 5, 2019Manufacturing and Production Asia, HIV, Singapore, anaemia, facilities, manufacturing, pharma
British multinational GlaxoSmithKline has opened two new manufacturing plants in Singapore. The UK firm has also expanded facilities at its …
ABPI Chief Executive Mike Thompson to retire by the end of 2019
July 5, 2019Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing ABPI, Mike Thompson, pharma
The Association of the British Pharmaceutical Industry (ABPI) has announced that its Chief Executive Mike Thompson is to retire from …
Top Ten most popular articles on Pharmafile.com this week!
July 5, 2019Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Brenntag, Elizabeth Warren, HIV, Novartis, PrEP, cannabis, crispr, pharma
The top story of this week covered Novartis’ announcement that they did not send chemicals that could be used to …
FDA sharpen focus on pharmaceutical companies under Trump
July 5, 2019Medical Communications FDA, Obama, Trump, USA, pharma, regulation
The overall number of warning letters being sent out by the FDA has dropped under President Donald Trump, according to …
NICE recommends Pfizer’s Vizimpro, rejects AstraZeneca’s Tagrisso, in non-small cell lung cancer
July 5, 2019Medical Communications, Sales and Marketing Cancer, NHS, NICE, Pfizer, UK, Vizimpro, lung cancer, pharma
NICE has announced its decision to recommend Pfizer’s Vizimpro (Dacomitinib) in the treatment of non-small-cell lung cancer (NSCLC) – a …
Latest content
NIHR chief scientific adviser visits Huddersfield health innovation campus
One in three UK women with migraine say symptoms taken less seriously
Report highlights scope to expand day surgery
Sygnature formalises drug discovery collaboration with X-Chem
Codis appoints Steven Facer as chief commercial officer
